Wilhelmi G
Z Rheumatol. 1977 Mar-Apr;36(3-4):112-9.
Tribenoside, a D-glucofuranose derivative, was administered prophylactically over a period of ten months to six-month-old mice of the C 57 Black strain (Animal Breeding Unit, Sisseln), which are known to have a predisposition to spontaneous gonarthrosis. The preparation was given once daily for five consecutive days every other week in doses of 100 or 300 mg/kg p.o. At the end of the treatment period, serial sections of both knee joints were examined. In the placebo-treated controls, arthrotic lesions of varying severity were found in 97% of the specimens. In the animals given tribenoside in either dosage arthrotic lesions were significantly less frequent and less severe. The number of animals with bilateral gonarthrosis and of those with proliferative changes was also significantly or highly significantly smaller in the groups treated with tribenoside than in the controls. The only indication of a dose-related effect of the preparation was the fact that arthrosis of the most severe grade was present in fewer animals in the group treated with the higher dose. At present, the mechanism of action responsible for the protective effect of tribenoside demonstrated once again in these experiments cannot be clearly defined.
曲克芦丁,一种D - 呋喃葡萄糖衍生物,对已知易患自发性膝关节病的6月龄C 57黑种系小鼠(锡瑟尔动物繁殖单位)进行了为期十个月的预防性给药。每隔一周连续五天每天口服给药一次,剂量为100或300毫克/千克。在治疗期结束时,对两个膝关节的连续切片进行了检查。在接受安慰剂治疗的对照组中,97%的标本发现了不同严重程度的关节病变。在给予任一剂量曲克芦丁的动物中,关节病变的发生频率和严重程度均显著降低。与对照组相比,接受曲克芦丁治疗的组中双侧膝关节病动物数量以及出现增殖性变化的动物数量也显著或高度显著减少。该制剂唯一与剂量相关效应的迹象是,高剂量治疗组中出现最严重等级关节病的动物较少。目前,在这些实验中再次证明的曲克芦丁保护作用的作用机制尚不能明确定义。